← Back to Search

Communication Strategies for Children With Medical Complexity

N/A
Waitlist Available
Led By Jody L Lin, MD, MS
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after reviewing the intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial tests different ways to explain medical treatment options to parents of children with complex health issues. Participants watch a video and take a survey to see if the way information is presented affects their decision-making quality.

Who is the study for?
This trial is for adult caregivers of children with complex medical conditions. Participants must be able to speak English or Spanish. It's designed to help understand how best to communicate about treatment risks and benefits, aiming to improve decision-making quality.
What is being tested?
The study tests different communication strategies by having participants view a video simulating a clinic visit and then complete a survey. The goal is to see if the way information is presented affects the decisions caregivers make for their children.
What are the potential side effects?
Since this trial involves watching videos and completing surveys rather than testing medications, there are no direct physical side effects associated with participating in this research.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after reviewing the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after reviewing the intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Decision readiness
Secondary study objectives
Decision intent for treatment
Decisional Conflict Scale
Knowledge

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

16Treatment groups
Experimental Treatment
Active Control
Group I: Normalizing onlyExperimental Treatment1 Intervention
Receive information about normalizing language related to the clinical decision.
Group II: Normalizing and narratives onlyExperimental Treatment2 Interventions
Receive information about normalizing language and narratives related to the clinical decision.
Group III: Narratives onlyExperimental Treatment1 Intervention
Receive narratives in addition to the control condition.
Group IV: Complexity, normalizing, and narratives onlyExperimental Treatment3 Interventions
Receive information about complexity, normalizing language, and narratives related to the clinical decision.
Group V: Complexity onlyExperimental Treatment1 Intervention
Receive information about complexity related to the clinical decision.
Group VI: Complexity and normalizing onlyExperimental Treatment2 Interventions
Receive information about complexity and normalizing language related to the clinical decision.
Group VII: Complexity and narratives onlyExperimental Treatment2 Interventions
Receive information about complexity and narratives related to the clinical decision.
Group VIII: Ambiguity, normalizing, and narratives onlyExperimental Treatment3 Interventions
Receive information about ambiguity, normalizing language, and narratives related to the clinical decision.
Group IX: Ambiguity, complexity, and normalizing onlyExperimental Treatment3 Interventions
Receive information about ambiguity, complexity, and normalizing language related to the clinical decision.
Group X: Ambiguity, complexity, and narratives onlyExperimental Treatment3 Interventions
Receive information about ambiguity, complexity, and narratives related to the clinical decision.
Group XI: Ambiguity onlyExperimental Treatment1 Intervention
Receive information about ambiguity related to the clinical decision.
Group XII: Ambiguity and normalizing onlyExperimental Treatment2 Interventions
Receive information about ambiguity and normalizing language related to the clinical decision.
Group XIII: Ambiguity and narratives onlyExperimental Treatment2 Interventions
Receive information about ambiguity and narratives related to the clinical decision.
Group XIV: Ambiguity and complexity onlyExperimental Treatment2 Interventions
Receive information about ambiguity and complexity related to the clinical decision.
Group XV: AllExperimental Treatment4 Interventions
Receive all new communication approaches
Group XVI: ControlActive Control1 Intervention
No new communication approaches received.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ambiguity
2023
N/A
~830
Complexity
2023
N/A
~830
Narrative
2017
N/A
~1170
Normalizing language
2023
N/A
~830

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,138 Previous Clinical Trials
1,790,840 Total Patients Enrolled
Children's Hospital Los AngelesOTHER
246 Previous Clinical Trials
5,072,516 Total Patients Enrolled
1 Trials studying Multiple Chronic Conditions
160 Patients Enrolled for Multiple Chronic Conditions
Jody L Lin, MD, MSPrincipal InvestigatorUniversity of Utah

Media Library

Normalizing only Clinical Trial Eligibility Overview. Trial Name: NCT05913206 — N/A
Multiple Chronic Conditions Research Study Groups: Normalizing only, Ambiguity and normalizing only, Normalizing and narratives only, Complexity, normalizing, and narratives only, Ambiguity, complexity, and normalizing only, Ambiguity, complexity, and narratives only, Narratives only, Ambiguity, normalizing, and narratives only, Complexity and narratives only, Ambiguity and narratives only, Ambiguity and complexity only, Ambiguity only, Control, All, Complexity only, Complexity and normalizing only
Multiple Chronic Conditions Clinical Trial 2023: Normalizing only Highlights & Side Effects. Trial Name: NCT05913206 — N/A
Normalizing only 2023 Treatment Timeline for Medical Study. Trial Name: NCT05913206 — N/A
~354 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top